ReviewCureus2024

Novel Pharmaceuticals and Therapeutics for Tumor Necrosis Factor-Alpha-Resistant Crohn's Disease: A Narrative Review.

Blake Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.